Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
05.01.24 | Core Scientific Announces December and Full Year 2023 Production and Operations Updates | 233 | Business Wire | AUSTIN, Texas--(BUSINESS WIRE)--Core Scientific, Inc. (OTC: CORZQ) ("Core Scientific" or "the Company"), a leader in high-performance blockchain computing data centers and software solutions, today... ► Artikel lesen | |
05.01.24 | Ligand Pharmaceuticals Incorporated: U.S. Food and Drug Administration Approves ZELSUVMI as a First-in-Class Medication for the Treatment of Molluscum Contagiosum | 263 | Business Wire | SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that the U.S. Food and Drug Administration (FDA) has approved ZELSUVMI (berdazimer topical gel, 10.3%)... ► Artikel lesen | |
05.01.24 | Gold Reserve Announces Further Management and Board Changes | 230 | Business Wire | SPOKANE, Wash.--(BUSINESS WIRE)--Further to its press release of November 27, 2023 announcing the retirement of Rockne J. Timm as Chief Executive Officer of Gold Reserve Inc. (TSX.V:GRZ) (OTCQX:GDRZF)... ► Artikel lesen | |
05.01.24 | Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 5 January 2024 | 498 | Business Wire | Regulatory News:
Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (NA:PSH) ("PSH") today announced that it has purchased, through PSH's agent, Jefferies International Limited ("Jefferies"), the... ► Artikel lesen | |
05.01.24 | Afiniti ernennt Mike Myshrall zum CFO | 548 | Business Wire | Afiniti, ein führender Anbieter von Anwendungen und Infrastruktur für künstliche Intelligenz (KI) im Bereich Customer Experience (CX), gibt die Ernennung von Mike Myshrall zum Chief Financial Officer... ► Artikel lesen | |
05.01.24 | Delta-Fly Pharma, Inc.: Delta-Fly Pharma Inc.: Aktueller Stand der Forschung und Entwicklung von DFP-10917 und DFP-14927, einem neuartigen PEG-Wirkstoffkonjugat für Patienten mit R/R AML | 434 | Business Wire | Nach der letzten Information über den 30.Juni 2023 freuen wir uns, Ihnen unseren neuesten Entwicklungsstand mitteilen zu können.
Eine Phase-III-Studie mit DFP-10917 und Patienten mit rezidivierender... ► Artikel lesen | |
05.01.24 | Quectel Wireless Solutions: Quectel reagiert auf die Forderung des House Select Committee on China, eine Sperre von US-Investitionen in das Unternehmen in Betracht zu ziehen | 384 | Business Wire | Quectel Wireless Solutions, ein globaler Anbieter von IoT-Lösungen, hat mit der nachstehenden Erklärung auf die jüngste Aufforderung des Select Committee on China des US-Repräsentantenhauses an die... ► Artikel lesen | |
05.01.24 | Omniose gibt wissenschaftliche Zusammenarbeit mit AstraZeneca zur Erforschung von Impfstoffen gegen ernsthafte bakterielle Erkrankungen bekannt | 691 | Business Wire | Dank der Zusammenarbeit erhält AstraZeneca exklusive Rechte an der Biokonjugationsplattform von Omniose zur Erforschung von möglichen Impfstoffen gegen zahlreiche bakterielle Pathogene
Omniose... ► Artikel lesen | |
05.01.24 | HistoSonics: Weltweit erste Patienten mit dem neuartigen Edison Histotripsie-System behandelt | 428 | Business Wire | Führende US-Zentren starten innovative Programme zur Behandlung der Leber mit Histotripsie
HistoSonics (www.histosonics.com), der Hersteller des nicht-invasiven Edison® Histotripsie-Systems, gab... ► Artikel lesen | |
05.01.24 | Teleperformance SE: Statement on Transactions on Own Shares Carried out from December 29, 2023 to January 4, 2024 (inclusive) | 520 | Business Wire | (Article 5 §2 of the Regulation (EU) No 596/2014 of April 16, 2014 on market abuse)
Regulatory News:
Teleperformance SE (Paris:TEP) purchased certain of its own shares in connection with the... ► Artikel lesen | |
05.01.24 | GeNeuro Names Anke Post as Chief Medical Officer, Following Retirement of David Leppert who Becomes a Consultant to GeNeuro | 632 | Business Wire | Regulatory News:
GeNeuro (Euronext Paris: CH0308403085 GNRO), a biopharmaceutical company focused on stopping the progression of neurodegenerative and autoimmune diseases such as multiple sclerosis... ► Artikel lesen | |
05.01.24 | CARMAT Announces the Approval of All Resolutions Supported by the Board of Directors at its Extraordinary General Meeting | 446 | Business Wire | Regulatory News:
CARMAT (FR0010907956, ALCAR), designer and developer of Aeson®, the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering... ► Artikel lesen | |
05.01.24 | JBT Corporation Receives Extension of PUSU Deadline for Proposal to Merge With Marel | 533 | Business Wire | CHICAGO--(BUSINESS WIRE)--JBT Corporation (NYSE: JBT) ("JBT"), a leading global technology solutions provider to high-value segments of the food & beverage industry, today announced that the Financial... ► Artikel lesen | |
05.01.24 | AM Best Affirms Credit Ratings of Liva Group SAOG | 562 | Business Wire | AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of "a-" (Excellent) of Liva Group SAOG (Liva Group) (Oman). The outlook of these Credit... ► Artikel lesen | |
05.01.24 | Kenvue Inc.: Kenvue veröffentlicht am 8. Februar 2024 seine Ergebnisse für das vierte Quartal und das Gesamtjahr 2023 | 745 | Business Wire | Kenvue Inc. (NYSE: KVUE) ("Kenvue"), das gemessen am Umsatz größte reine Gesundheitsunternehmen der Welt, wird seine Finanzergebnisse für das vierte Quartal und das am 31. Dezember 2023 zu Ende gegangene... ► Artikel lesen | |
05.01.24 | Forum Energy Technologies Completes Acquisition of Variperm Energy Services | 359 | Business Wire | HOUSTON--(BUSINESS WIRE)--Forum Energy Technologies, Inc. (NYSE: FET) today announced it has completed the acquisition of Variperm Energy Services ("Variperm"), a leading manufacturer of customized... ► Artikel lesen | |
05.01.24 | Green Plains Inc. and Green Plains Partners LP Announce Unitholder Approval of Merger | 225 | Business Wire | OMAHA, Neb.--(BUSINESS WIRE)--Green Plains Inc. (NASDAQ: GPRE) ("Green Plains") and Green Plains Partners LP (NASDAQ: GPP) (the "Partnership") today announced that the Partnership's common unitholders... ► Artikel lesen | |
05.01.24 | Personalis Reports Preliminary Fourth Quarter and Full Year 2023 Revenue and Cash Balance | 427 | Business Wire | FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported unaudited preliminary revenue for the fourth quarter and... ► Artikel lesen | |
05.01.24 | AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance | 254 | Business Wire | LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system... ► Artikel lesen | |
05.01.24 | Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-Year 2023 Net Revenue Results | 285 | Business Wire | ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today provided an update on its 2023 fourth quarter and full year business... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
TESLA | 3.799 |
NVIDIA | 3.206 |
RHEINMETALL | 2.044 |
RENK GROUP | 1.779 |
THYSSENKRUPP | 1.683 |
STEYR MOTORS | 1.618 |
BYD | 1.580 |
BAYER | 1.563 |
NEL | 1.457 |
DEUTZ | 1.446 |
TUI | 1.404 |
VOLKSWAGEN | 1.231 |
EVOTEC | 1.149 |
NOVO NORDISK | 1.131 |
MERCEDES-BENZ | 1.012 |
XIAOMI | 945 |
AMAZON | 936 |
PUMA | 891 |
PORSCHE AG | 874 |
BASF | 860 |
COMMERZBANK | 786 |
DEUTSCHE BANK | 784 |
NORDEX | 772 |
AIXTRON SE | 729 |
VONOVIA | 640 |